Hawaii 2026 Regular Session

Hawaii Senate Bill SR44

Introduced
3/10/26  
Refer
3/19/26  
Report Pass
4/8/26  

Caption

Supporting The Department Of Health's Efforts To Coordinate The Stockpiling Of A Three-year Supply Of Mifepristone.

Impact

If enacted, SR44 will enhance the state's ability to provide equitable access to abortion services, particularly in light of the concentration of surgical abortion facilities on the islands of Maui and Oahu. By maintaining a ready supply of mifepristone, the state aims to mitigate any potential disruption in healthcare provision that may arise from national policy shifts or supply chain issues related to reproductive health medications. This measure reflects Hawaii’s commitment to abortion rights, safety, and healthcare equity, particularly for vulnerable populations including youth and young adults seeking such services.

Summary

Senate Resolution 44 (SR44) supports the Department of Health's initiative to stockpile a three-year supply of mifepristone, a medication essential for medical abortions. As the legal landscape around reproductive health continues to evolve, particularly following the Supreme Court's 2022 decision in Dobbs v. Jackson Women's Health Organization, SR44 underscores Hawaii's commitment to protecting the bodily autonomy and reproductive rights of its residents. This resolution reaffirms the state’s long-standing tradition of safeguarding individual rights and ensuring access to necessary healthcare services.

Sentiment

The overall sentiment around SR44 appears to be positive among supporters of reproductive rights, who view the resolution as a proactive step towards ensuring continued access to safe abortion services. However, discussions may also reflect concern from opponents regarding the provision of abortion services, particularly in a changing national context that could influence local policies. The resolution serves as a reminder of the ongoing struggle to protect reproductive rights amidst fluctuating federal regulations.

Contention

Notable points of contention around SR44 include the ongoing national debate surrounding abortion rights, particularly after the Dobbs decision. Critics may argue that stockpiling mifepristone could be misinterpreted or misused in various contexts. Moreover, there is concern about the potential for neighboring states to influence Hawaii's policies, with some places imposing stricter regulations on abortion that could impact Hawaii's approach. The resolution aims to serve as a bulwark against such external pressures, ensuring that the rights to privacy and bodily autonomy enshrined in the state constitution remain upheld.

Companion Bills

HI SCR45

Same As Supporting The Department Of Health's Efforts To Coordinate The Stockpiling Of A Three-year Supply Of Mifepristone.

HI HR37

Same As Urging The Department Of Health To Coordinate The Stockpiling Of A Three-year Supply Of Mifepristone.

Previously Filed As

HI SR119

Strongly Supporting The Construction Of A Floating Drydock At Pearl Harbor.

HI SR176

Supporting And Encouraging A Broader Relationship Between The State And The Kingdom Of Norway.

HI SB1246

Relating To Health Care.

HI SR38

Supporting The Native Hawaiian Intellectual Property Working Group's Request For Resources And Timeline Extension For Fiscal Year 2025-2026.

HI SR26

Strongly Supporting And Recommending The Implementation Of The Revised 2025 Hawaii Patient Bill Of Rights.

HI SR28

Strongly Supporting And Recommending The Implementation Of The Revised 2025 Hawaii Patient Bill Of Rights.

HI HB866

Relating To Health Care.

HI SR175

Supporting And Encouraging A Broader Relationship Between The State And The Kingdom Of Sweden.

HI SR17

Endorsing Taiwan's International Participation, Supporting The Signing Of A United States-taiwan Bilateral Trade Agreement, And Commemorating The Relationships And Exchanges Between The State Of Hawaii And Taiwan.

HI SCR148

Strongly Supporting The Construction Of A Floating Drydock At Pearl Harbor.

Similar Bills

No similar bills found.